Charles River Unrelenting Microbial Solutions

Rapid test 2019-nCoV Total Immunoglobulins (V1210/V1230)

Rapid Test 2019 nCoV

Principle: Lateral flow method

Automation: No

Approvals: Currently Under approval by FDA, Pending CE IVD mark

Suitability: Medical teams, countries’ entry points, suitable for field use

Capital equipment required: No


Rapid test 2019-nCoV Total is a qualitative Lateral Flow test for the determination of IgA, IgM, and IgG antibodies against SARS-CoV-2 in human serum, plasma, or whole blood specimens.

Key Points:
  • Lateral flow in dip stick format available in 10 or 30 test sticks
  • Clinical Diagnostic Sensitivity (98.75%) and Clinical Diagnostic Specificity (100%)
  • Low procedure time: 10 min
  • Easy-to-use method, no need for equipment or special facilities
  • Visual interpretation of the results
  • Shelf Life: 12 months | Storage 4-30°C


Company contact details:

ProGnosis Biotech S.A view full details

Website: Visit Website
Tel: + 30-2410623922